LncRNA | MiRNA | Gene | Gene name | Pathway Name | Description | Title | Disease/Tissue | Journal | PubMed ID |
ROR | miR-145 | FSCN1 | FSCN1;FAN1;HSN;SNL;p55 | details | details
The function of linc-ROR exerted in LAD cells depended on the sponging of miR-145, therefore, releasing the miR-145 target FSCN1, and thus contributing to the acquisition of chemoresistance and EMT phenotypes of docetaxel-resistant LAD cells.
|
details
Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway
|
Lung Adenocarcinoma | Oncotarget | 28388536 |
UCA1 | miR-145 | FSCN1 | FSCN1;FAN1;HSN;SNL;p55 | details | details
Mechanistically, lncRNA-UCA1 induced EMT of bladder cancer cells by upregulating the expression levels of zinc finger E-box binding homeobox 1 and 2 (ZEB1 and ZEB2), and regulated bladder cancer cell migration and invasion by tumor suppressive hsa-miR-145 and its target gene the actin-binding protein fascin homologue 1 (FSCN1).
|
details
Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN3 pathway
|
Bladder Cancer | Cancer Sci | 26544536 |
LincRNA-ROR | miR-145 | FSCN1 | FSCN1;FAN1;HSN;SNL;p55 | details | details
ROR acted as a competitive endogenous RNA (ceRNA) of miR-145 in ESCC. A novel, effective miR-145 binding site of ROR was discovered. The ROR/miR-145/FSCN1 pathway was shown to take part in the metastasis of ESCC. ROR is likely an oncogene biomarker for ESCC early diagnosis and prognosis
|
details
LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1
|
Esophageal squamous cell carcinoma | Onco Targets Ther | 29430188 |
XIAP | miR-29a-5p | FSCN1 | FSCN1;FAN1;HSN;SNL;p55 | details | details
Furthermore, we demonstrated that one miRNA, miR-29a-5p, can bind to both the XIAP and FSCN1 3'UTRs and play an important role in that interactions.
|
details
XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p
|
Breast Cancer | Oncotarget | 28186968 |